UOC
SRZNW icon

UBS O'Connor’s Surrozen Inc Warrant SRZNW Stock Holding History

UBS O'Connor’s Portfolio SRZNW Stock Details SRZNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-83,330
Closed -$125K – 986
2021
Q2 		$125K Buy
83,330
+54
+0.1% +$59 ﹤0.01% 795
2021
Q1 		$59K Buy
+83,276
New +$142K ﹤0.01% 789

Other funds holding SRZNW

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

UBS O'Connor's SRZNW Position: Q3 2021 in Review

UBS O'Connor sold out of Surrozen Inc Warrant (SRZNW) in Q3 2021, closing a stake of 83,330 shares — an estimated $125K sold.

UBS O'Connor first reported a position in SRZNW in Q1 2021 and held it in 2 quarters. The position peaked at $125K in Q2 2021. 18 funds tracked by Wall St. Rank hold SRZNW as of Q3 2021.

  • UBS O'Connor reported no remaining Surrozen Inc Warrant position as of Q3 2021 after selling out during the quarter.
  • UBS O'Connor sold 83,330 Surrozen Inc Warrant shares in Q3 2021, an estimated $125K.
  • UBS O'Connor first reported a position in Surrozen Inc Warrant in Q1 2021 and held it in 2 quarters.
  • UBS O'Connor's Surrozen Inc Warrant position peaked at $125K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Surrozen Inc Warrant as of Q3 2021.

Based on UBS O'Connor's 13F filing for Q3 2021, filed 12 Nov 2021.